Company facts
- Headquarters
- South San Francisco, California
- Most recent report
- 10-Q, filed Nov 6, 2026
- Incorporated
- N/A
- Filings on record
- 586 filings
- On EDGAR
- CIK 1737287
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 34
News 8 of 87
Prospectuses and Registrations 8 of 25
- S-3 Shelf registration statement Aug 12, 2026
- 424B5 Prospectus supplement for an offering Jun 22, 2026
- 424B5 Prospectus supplement for an offering Apr 15, 2026
- 424B5 Prospectus supplement for an offering Apr 13, 2026
- S-8 Registration statement for an employee plan Mar 12, 2026
- S-8 Registration statement for an employee plan Mar 13, 2025
- 424B5 Prospectus supplement for an offering May 14, 2024
- S-8 Registration statement for an employee plan Mar 14, 2024
Proxies 8 of 20
- DEFA14A Extra proxy material May 28, 2026
- DEFA14A Extra proxy material May 21, 2026
- DEFA14A Extra proxy material Apr 30, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- PRE 14A Preliminary proxy statement Apr 20, 2026
- DEFA14A Extra proxy material Apr 30, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2025
- DEFA14A Extra proxy material Apr 23, 2024
Ownership 8 of 385
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 27, 2026
- 4 Insider reported a trade Oct 23, 2026
- 144 Notice of a proposed sale of restricted stock Oct 21, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Sep 30, 2026
- 4 Insider reported a trade Aug 25, 2026
- 144 Notice of a proposed sale of restricted stock Aug 21, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 7, 2026
Other 8 of 35
- EFFECT Notice that a registration became effective Aug 20, 2026
- ARS Annual report sent to shareholders Apr 30, 2026
- ARS Annual report sent to shareholders Apr 30, 2025
- EFFECT Notice that a registration became effective Apr 25, 2024
- CORRESP Reply to SEC staff Apr 23, 2024
- ARS Annual report sent to shareholders Apr 23, 2024
- UPLOAD Comment letter from SEC staff Mar 19, 2024
- POSASR Mar 14, 2024
Everything here comes from Allogene Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.